About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

El informe

Noticias verificadas sobre financiación, sedes y liderazgo de las empresas más innovadoras del mundo

197 informes y contando

Actualizado diariamente con la última inteligencia de mercado
Fundraising
Crystalys Therapeutics

Crystalys Therapeutics Raises $130M Series B for Gout Drug Development

Crystalys Therapeutics raised an oversubscribed $130 million Series B led by Frazier Life Sciences to advance clinical development and commercialization preparation of dotinurad for gout.

SalesTools Research
Jul 22, 2026
2 min read•$130M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Fundraising
Crystalys Therapeutics

Crystalys Therapeutics Raises $205M in Series A

Crystalys Therapeutics, a Biotech company based in San Diego, CA, has raised $205M in Series A at a $800M valuation led by Novo Holdings, SR One, Catalys Pacific.

Fundraising News Team
Oct 3, 2025
0 min read
Biotech
Crystalys Therapeutics

Crystalys Therapeutics Raises $205M Series A to Transform Biotech

Crystalys Therapeutics has secured $205M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage biopharmaceutical company developing next-generation oral URAT1 inhibitor dotinurad for the treatment of ...

Emma Rodriguez
Oct 4, 2025
0 min read•$205M Series A
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Expedition Therapeutics

Expedition Therapeutics raises $165M Series B at $850M valuation

Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...

Editorial Team
Jan 15, 2025
0 min read•$165M
Página 1

Mostrando 9 informes • Página 1 • Categoría: all

Mantente a la vanguardia del mercado

Recibe insights semanales en tu bandeja de entrada. Sin spam, solo inteligencia.